CVX — Chevron Corporation

Post-Q2 2026, sentiment is constructive: adjusted EPS of $6.06 beat consensus, production rose 5% sequentially, an Angola oil discovery was announced, and Project Kilby lends a long-duration, commodity-agnostic earnings angle. Analyst consensus is Buy with a target near $211-214, and as of 2026-08-27 the chart is in an uptrend; minor insider selling and Barclays trimming to $208 keep the tone from being euphoric.

Revenue was effectively range-bound at $44-52B per quarter from 2023 through Q1 2026, then jumped to $67.2B in Q2 2026. That is a step-change, not a gradual trend: Q2 revenue was up ~51% YoY and operating margin jumped to ~32%, but the prior quarters show flattish organic revenue and normal commodity-driven margin swings. Q1 2026 gross margin of 9.6% versus Q2's 45.5% also flags non-comparable items, so the cleanest read is that the base business was stable-to-modestly-growing and Q2-2026 should be treated as a new, unproven baseline rather than part of a smooth uptrend.

Mixed. On trailing data, CVX is rich: P/E is 19.1x versus its 5-year average of 15.0x, and P/S is 1.91x versus 1.44x. But against next-fiscal-year consensus EPS of $15.89, the forward P/E is roughly 12.6x, and PEG is 0.56, which looks cheap if that earnings power is real. The entire valuation question comes down to whether Q2 2026's earnings jump annualizes or was a one-off acquisition/accounting distortion.

At $199.63 as of 2026-08-27, the market is giving CVX credit for a step-up that has not yet been confirmed by a full year of clean earnings: trailing EPS is $10.45, making the stock look expensive, while the $15.89 forward estimate makes it look cheap. This is a 'show-me' setup: watch Q3/Q4 cash flow, production, and Hess integration updates. If the run-rate confirms, the stock is not asking for much; if it doesn't, a reversion toward $170-180 is plausible.

Trending higher, not overbought. As of 2026-08-27, RSI-14 was 56.5, price was +0.9% above the 20-day SMA, +6.7% above the 50-day, and +11.2% above the 200-day. That is a healthy uptrend with room before overbought, but 11% above the 200-day suggests buying strength is less attractive; dips toward the 50-day area around $187-190 would offer a better entry.

• Crude oil price and OPEC+ supply decisions, with a persistent geopolitical premium around Middle East shipping lanes such as the Strait of Hormuz.
• Global GDP/China demand and the risk that higher interest rates slow energy consumption.
• Energy transition/electrification: data-center power demand creates new, less cyclical revenue streams like Project Kilby.
• U.S. regulatory/foreign-policy shifts, including potential changes in access to Venezuelan or other heavy crude supplies.
• Natural gas/LNG prices and refining margins, which drive downstream earnings alongside upstream crude exposure.

• Q3 2026 earnings in late October/early November 2026: Permian production run-rate, capex, free cash flow, and Hess integration updates.
• Oil-price catalysts: OPEC+ meetings, Strait of Hormuz disruptions, or U.S. supply-policy changes.
• Further data-center power contracts or scaling of New Energies/Project Kilby beyond Microsoft.
• Exploration/appraisal results in Angola, Guyana, or other high-impact prospects leading to new FIDs.

• Sustained decline in crude or natural gas prices, compressing revenue, margins, and free cash flow.
• Q2 2026 earnings quality: the revenue/profit step-up may include one-off/acquisition items that do not repeat.
• Hess integration, project execution, or legal/arbitration issues that delay synergies or cause cost overruns.
• Mean reversion in the trailing multiple if forward EPS estimates prove too high.
• Long-term energy-transition regulation, climate litigation, and demand-displacement risks.

CVX is a financially solid, conservatively leveraged integrated major with a better growth story than most oil peers, but the stock is not historically cheap and the latest quarter's earnings jump is not a clean organic signal. The risk/reward is constructive rather than compelling, so the sensible posture is to be a cautious buyer on weakness rather than a chaser near the top of the 52-week range.

I applied a 14.0x forward P/E multiple to next-fiscal-year consensus EPS of $15.89. The multiple is the 5-year average P/E of 15.0x discounted by one turn for commodity cyclicality and Q2 earnings-quality risk, producing a fair value of $222.45 as of 2026-08-27.